Author: Hartmann H.M.
Publisher: Academic Press
ISSN: 0273-2300
Source: Regulatory Toxicology and Pharmacology, Vol.35, Iss.3, 2002-06, pp. : 347-356
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 9, Iss. 3, 2006-05 ,pp. :
A Benefit-Risk Assessment of Class III Antiarrhythmic Agents
By Brendorp B.
Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. :
A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis
By Gupta A.K.
Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. :